Laia Curto Barredo

Dr. Laia Curto Barredo

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
GDG Deza
G Deza
MBM Bertolín-Colilla
M Bertolín-Colilla
RPR Pujol
R Pujol
LBLaia Curto Barredo
Laia Curto Barredo
DSD Soto
D Soto
AGA Giménez-Arnau
A Giménez-Arnau
Although the efficacy of omalizumab has been clearly demonstrated in the treatment of chronic sponta...

1 July 2018 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
LBLaia Curto Barredo
Laia Curto Barredo
LAL Archilla
L Archilla
GVG Vives
G Vives
RPR Pujol
R Pujol
AGA Giménez-Arnau
A Giménez-Arnau
Chronic spontaneous urticaria (CSU) is characterized by heterogeneous activity, evolution, associated comorbidities and response to treatment. The aim of this study was to identify prognostic factors in patients with CSU that predict disease course and response to standard treatments. An observational retrospective study was conducted in a cohort of 549 patients with CSU, comparing patients with isolated CSU and those with CSU with concomitant inducible urticaria (CSU-CIndU). The factors associated with a worse prognosis in terms of duration and/or CSU activity and its episodes were: multiple episodes of CSU (19.2% had more than one lifetime episode of CSU), late-onset (63.6% of patients developed first onset of CSU after the age of 45 years), concomitant CIndU (20.2%) and functional serum autoreactivity. Patients with CSU-CIndU required more frequent therapy after 5 years and higher doses of 2nd-generation H1-antihistamines. Of patients with a baseline Urticaria Activity Score 7 (UAS7) between 16 and 42, 84.6% required cyclosporine or omalizumab to achieve symptom control, compared with 15.4% of patients with a baseline UAS7 between 0 and 15 (p?=?0.0013). Baseline CSU activity is the only factor found to be predictive for refractoriness to treatment with H1-antihistamines.

24 January 2018 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
LBLaia Curto Barredo
Laia Curto Barredo
JSJ. Spertino
J. Spertino
IFI. Figueras-Nart
I. Figueras-Nart
VEV. Expósito-Serrano
V. Expósito-Serrano
AGA. Guilabert
A. Guilabert
AGA. Giménez-Arnau
A. Giménez-Arnau

4 October 2016 in Immunity, Inflammation and Disease
Verified
Journal Article
Open access
PDF file
LBLaia Curto Barredo
Laia Curto Barredo
JYJose Yelamos
Jose Yelamos
RGRamon Gimeno
Ramon Gimeno
SMSergi Mojal
Sergi Mojal
RPRamòn María Pujol
Ramòn María Pujol
AGAna M. M Giménez-Arnau
Ana M. M Giménez-Arnau
Introduction: The basophil activation test showing CD63 up regulation could be a specific and sensitive in vitro complementary text to the in vivo autologous serum skin test for the activity assessment of the patients suffering autoimmune chronic spontaneous urticaria. The aim of this study is to define the basophil activation test as a useful tool in clinical practice in order to identify those patients with more active disease.Methods: We screened 139 patients (96 women) diagnosed of chronic spontaneous urticaria using simultaneously autologous serum skin test and basophil activation test and their relationship with disease activity.Results: Positive autologous serum skin test was found in 56.8%; from them, 31.6% were basophil activation test positive. Negative autologous serum skin test result was found in the 43.2% of the sample that showed negative CD63 expression results in all cases, except one. Patients with positive autologous serum skin test and positive CD63 by basophil activation test showed significant higher Urticaria Activity Score of 7 days (P = 0.004) and of 3 weeks (P = 0.001) than patients with positive autologous serum skin test and negative CD63 (mean ± standard deviation [SD] 26.57 ± 10.56 versus 18.40 ± 12.05 for the Urticaria Activity Score of 7 days and 56.47 ± 23.78 versus 39.88 ± 25.44 for the Urticaria Activity Score of 3 weeks).Conclusions: The CD63 expression on basophils appears as a reliable in vitro marker, useful in clinical practice in combination with autologous serum skin test to define chronic spontaneous urticaria patients with the highest urticaria activity that impairs a normal life.

1 January 2016 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
MAM Abajian
M Abajian
LBLaia Curto Barredo
Laia Curto Barredo
KKK Krause
K Krause
ESE Santamaria
E Santamaria
III Izquierdo
I Izquierdo
AGA Giménez-Arnau
A Giménez-Arnau
Chronic cold urticaria (ColdU) is a rare disease characterized by mast cell-mediated wheals and angioedema following cold exposure. Second-g...

26 May 2017 in Allergy
Verified
Journal Article
Closed access
PDF file
AGAna M. M Giménez-Arnau
Ana M. M Giménez-Arnau
LBLaia Curto Barredo
Laia Curto Barredo
LNL. Nonell
L. Nonell
EPE. Puigdecanet
E. Puigdecanet
JYJose Yelamos
Jose Yelamos
RPRamòn María Pujol
Ramòn María Pujol